203 related articles for article (PubMed ID: 31888144)
1. Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease.
Gaggini M; Carli F; Rosso C; Younes R; D'Aurizio R; Bugianesi E; Gastaldelli A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31888144
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin levels and insulin resistance among patients with chronic hepatitis C.
Carvalho RF; Atta AM; de Oliveira IS; Santos TPS; Santos JPA; Schinoni MI; de Sousa-Atta MLB
Acta Trop; 2018 Feb; 178():258-263. PubMed ID: 29217381
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
[TBL] [Abstract][Full Text] [Related]
5. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.
Andrade VG; Yamashiro FDS; Oliveira CV; Moreira A; Winckler FC; Silva GF
Arq Gastroenterol; 2018; 55(3):274-278. PubMed ID: 30540091
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].
Hui JM; Sud A; Farrell GC; Bandara P; Byth K; Kench JG; McCaughan GW; George J
Gastroenterology; 2003 Dec; 125(6):1695-704. PubMed ID: 14724822
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
[TBL] [Abstract][Full Text] [Related]
8. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in non-diabetic patients with chronic hepatitis C: what does it mean?
Souza AF; Pace FH; Chebli JM; Ferreira LE
Arq Bras Endocrinol Metabol; 2011 Aug; 55(6):412-8. PubMed ID: 22011858
[TBL] [Abstract][Full Text] [Related]
10. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment.
Derbala M; Rizk N; Al-Kaabi S; Amer A; Shebl F; Al Marri A; Aigha I; Alyaesi D; Mohamed H; Aman H; Basem N
J Viral Hepat; 2009 Oct; 16(10):689-96. PubMed ID: 19486470
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.
Abd El-Wahab EW; Mikheal A; Sidkey F; Shatat HZ
J Med Virol; 2015 Mar; 87(3):428-40. PubMed ID: 25583244
[TBL] [Abstract][Full Text] [Related]
14. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
Cua IH; Hui JM; Kench JG; George J
Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
[TBL] [Abstract][Full Text] [Related]
15. Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease.
Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watababe S; Kubota S; Senda S; Masaki T
Nutr Res; 2011 Nov; 31(11):829-35. PubMed ID: 22118753
[TBL] [Abstract][Full Text] [Related]
16. Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.
Aghemo A; Prati GM; Rumi MG; Soffredini R; D'Ambrosio R; Orsi E; De Nicola S; Degasperi E; Grancini V; Colombo M
Hepatology; 2012 Nov; 56(5):1681-7. PubMed ID: 22619107
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.
Dai CY; Yeh ML; Huang CF; Hou CH; Hsieh MY; Huang JF; Lin IL; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML; Tung HD
J Gastroenterol Hepatol; 2015 May; 30(5):879-84. PubMed ID: 23808794
[TBL] [Abstract][Full Text] [Related]
18. Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs.
El Sagheer G; Soliman E; Ahmad A; Hamdy L
Libyan J Med; 2018 Dec; 13(1):1435124. PubMed ID: 29451090
[TBL] [Abstract][Full Text] [Related]
19. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.
Chang ML; Kuo CJ; Pao LH; Hsu CM; Chiu CT
Virulence; 2017 Oct; 8(7):1255-1264. PubMed ID: 28267407
[TBL] [Abstract][Full Text] [Related]
20. [HOMA-IR in patients with chronic hepatitis C].
Botshorishvili T; Vashakidze E
Georgian Med News; 2012 Feb; (203):33-7. PubMed ID: 22466538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
